nodes	percent_of_prediction	percent_of_DWPC	metapath
Nimodipine—CACNB4—prostate gland—urinary bladder cancer	0.0199	0.0681	CbGeAlD
Nimodipine—CACNB1—prostate gland—urinary bladder cancer	0.0159	0.0544	CbGeAlD
Nimodipine—CACNB3—prostate gland—urinary bladder cancer	0.0152	0.0521	CbGeAlD
Nimodipine—CACNA1S—seminal vesicle—urinary bladder cancer	0.0144	0.0493	CbGeAlD
Nimodipine—CACNB3—seminal vesicle—urinary bladder cancer	0.0129	0.0441	CbGeAlD
Nimodipine—AHR—prostate gland—urinary bladder cancer	0.0113	0.0386	CbGeAlD
Nimodipine—CACNB2—prostate gland—urinary bladder cancer	0.0102	0.035	CbGeAlD
Nimodipine—CACNB3—urethra—urinary bladder cancer	0.0102	0.0349	CbGeAlD
Nimodipine—CACNB4—vagina—urinary bladder cancer	0.00982	0.0336	CbGeAlD
Nimodipine—AHR—seminal vesicle—urinary bladder cancer	0.00955	0.0327	CbGeAlD
Nimodipine—CACNA1D—prostate gland—urinary bladder cancer	0.00895	0.0306	CbGeAlD
Nimodipine—CYP3A4—urine—urinary bladder cancer	0.0085	0.0291	CbGeAlD
Nimodipine—CACNB3—female reproductive system—urinary bladder cancer	0.00832	0.0285	CbGeAlD
Nimodipine—CACNA1C—prostate gland—urinary bladder cancer	0.00826	0.0283	CbGeAlD
Nimodipine—AHR—smooth muscle tissue—urinary bladder cancer	0.00799	0.0274	CbGeAlD
Nimodipine—AHR—urethra—urinary bladder cancer	0.00756	0.0259	CbGeAlD
Nimodipine—CACNB3—vagina—urinary bladder cancer	0.00752	0.0257	CbGeAlD
Nimodipine—NR3C2—prostate gland—urinary bladder cancer	0.00752	0.0257	CbGeAlD
Nimodipine—NR3C2—seminal vesicle—urinary bladder cancer	0.00636	0.0218	CbGeAlD
Nimodipine—AHR—female reproductive system—urinary bladder cancer	0.00616	0.0211	CbGeAlD
Nimodipine—CACNA1C—smooth muscle tissue—urinary bladder cancer	0.00585	0.02	CbGeAlD
Nimodipine—AHR—vagina—urinary bladder cancer	0.00557	0.0191	CbGeAlD
Nimodipine—NR3C2—smooth muscle tissue—urinary bladder cancer	0.00532	0.0182	CbGeAlD
Nimodipine—NR3C2—renal system—urinary bladder cancer	0.00513	0.0175	CbGeAlD
Nimodipine—CACNB1—lymph node—urinary bladder cancer	0.00507	0.0174	CbGeAlD
Nimodipine—CACNB2—vagina—urinary bladder cancer	0.00506	0.0173	CbGeAlD
Nimodipine—NR3C2—urethra—urinary bladder cancer	0.00504	0.0172	CbGeAlD
Nimodipine—CACNB3—lymph node—urinary bladder cancer	0.00487	0.0167	CbGeAlD
Nimodipine—CACNA1C—female reproductive system—urinary bladder cancer	0.00451	0.0154	CbGeAlD
Nimodipine—NR3C2—female reproductive system—urinary bladder cancer	0.00411	0.014	CbGeAlD
Nimodipine—CACNA1C—vagina—urinary bladder cancer	0.00408	0.014	CbGeAlD
Nimodipine—CYP3A5—prostate gland—urinary bladder cancer	0.00407	0.0139	CbGeAlD
Nimodipine—NR3C2—vagina—urinary bladder cancer	0.00371	0.0127	CbGeAlD
Nimodipine—AHR—lymph node—urinary bladder cancer	0.00361	0.0123	CbGeAlD
Nimodipine—CACNB2—lymph node—urinary bladder cancer	0.00327	0.0112	CbGeAlD
Nimodipine—CACNA1D—lymph node—urinary bladder cancer	0.00286	0.00978	CbGeAlD
Nimodipine—CYP3A5—renal system—urinary bladder cancer	0.00277	0.00948	CbGeAlD
Nimodipine—Blood lactate dehydrogenase increased—Epirubicin—urinary bladder cancer	0.00272	0.00763	CcSEcCtD
Nimodipine—Dizziness—Valrubicin—urinary bladder cancer	0.00267	0.0075	CcSEcCtD
Nimodipine—Cardiac failure congestive—Gemcitabine—urinary bladder cancer	0.00264	0.00741	CcSEcCtD
Nimodipine—CACNA1C—lymph node—urinary bladder cancer	0.00264	0.00903	CbGeAlD
Nimodipine—Phlebitis—Cisplatin—urinary bladder cancer	0.00259	0.00727	CcSEcCtD
Nimodipine—Vomiting—Valrubicin—urinary bladder cancer	0.00257	0.00721	CcSEcCtD
Nimodipine—Rash—Valrubicin—urinary bladder cancer	0.00255	0.00715	CcSEcCtD
Nimodipine—Dermatitis—Valrubicin—urinary bladder cancer	0.00255	0.00714	CcSEcCtD
Nimodipine—Headache—Valrubicin—urinary bladder cancer	0.00253	0.0071	CcSEcCtD
Nimodipine—Blood lactate dehydrogenase increased—Doxorubicin—urinary bladder cancer	0.00252	0.00706	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Thiotepa—urinary bladder cancer	0.00251	0.00705	CcSEcCtD
Nimodipine—Dyspnoea—Mitomycin—urinary bladder cancer	0.00248	0.00696	CcSEcCtD
Nimodipine—Cardiac failure congestive—Cisplatin—urinary bladder cancer	0.00246	0.00691	CcSEcCtD
Nimodipine—Nausea—Valrubicin—urinary bladder cancer	0.0024	0.00673	CcSEcCtD
Nimodipine—NR3C2—lymph node—urinary bladder cancer	0.0024	0.00822	CbGeAlD
Nimodipine—Phlebitis—Etoposide—urinary bladder cancer	0.00238	0.00666	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Fluorouracil—urinary bladder cancer	0.00236	0.00661	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Etoposide—urinary bladder cancer	0.00235	0.0066	CcSEcCtD
Nimodipine—Cardiac failure congestive—Etoposide—urinary bladder cancer	0.00226	0.00633	CcSEcCtD
Nimodipine—Hyponatraemia—Cisplatin—urinary bladder cancer	0.00224	0.00629	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Cisplatin—urinary bladder cancer	0.00224	0.00627	CcSEcCtD
Nimodipine—Ileus—Epirubicin—urinary bladder cancer	0.00223	0.00626	CcSEcCtD
Nimodipine—Liver function test abnormal—Gemcitabine—urinary bladder cancer	0.00221	0.00621	CcSEcCtD
Nimodipine—Jaundice—Thiotepa—urinary bladder cancer	0.00214	0.006	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Gemcitabine—urinary bladder cancer	0.00212	0.00593	CcSEcCtD
Nimodipine—CYP3A4—renal system—urinary bladder cancer	0.00208	0.00711	CbGeAlD
Nimodipine—Hepatobiliary disease—Thiotepa—urinary bladder cancer	0.00208	0.00582	CcSEcCtD
Nimodipine—Ileus—Doxorubicin—urinary bladder cancer	0.00207	0.00579	CcSEcCtD
Nimodipine—Cramp muscle—Cisplatin—urinary bladder cancer	0.00201	0.00564	CcSEcCtD
Nimodipine—CYP3A5—vagina—urinary bladder cancer	0.00201	0.00687	CbGeAlD
Nimodipine—Diarrhoea—Mitomycin—urinary bladder cancer	0.00191	0.00534	CcSEcCtD
Nimodipine—Sweating increased—Cisplatin—urinary bladder cancer	0.00188	0.00527	CcSEcCtD
Nimodipine—Cramp muscle—Etoposide—urinary bladder cancer	0.00184	0.00517	CcSEcCtD
Nimodipine—Dizziness—Mitomycin—urinary bladder cancer	0.00184	0.00516	CcSEcCtD
Nimodipine—Cardiac disorder—Thiotepa—urinary bladder cancer	0.00183	0.00513	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Etoposide—urinary bladder cancer	0.00181	0.00506	CcSEcCtD
Nimodipine—Angiopathy—Thiotepa—urinary bladder cancer	0.00179	0.00502	CcSEcCtD
Nimodipine—Immune system disorder—Thiotepa—urinary bladder cancer	0.00178	0.00499	CcSEcCtD
Nimodipine—Vomiting—Mitomycin—urinary bladder cancer	0.00177	0.00497	CcSEcCtD
Nimodipine—Rash—Mitomycin—urinary bladder cancer	0.00176	0.00492	CcSEcCtD
Nimodipine—Dermatitis—Mitomycin—urinary bladder cancer	0.00176	0.00492	CcSEcCtD
Nimodipine—Hepatobiliary disease—Gemcitabine—urinary bladder cancer	0.00175	0.0049	CcSEcCtD
Nimodipine—Headache—Mitomycin—urinary bladder cancer	0.00175	0.00489	CcSEcCtD
Nimodipine—Sweating increased—Etoposide—urinary bladder cancer	0.00172	0.00483	CcSEcCtD
Nimodipine—CYP3A4—female reproductive system—urinary bladder cancer	0.00167	0.0057	CbGeAlD
Nimodipine—Nausea—Mitomycin—urinary bladder cancer	0.00165	0.00464	CcSEcCtD
Nimodipine—Hepatobiliary disease—Cisplatin—urinary bladder cancer	0.00163	0.00457	CcSEcCtD
Nimodipine—Anaemia—Thiotepa—urinary bladder cancer	0.00159	0.00445	CcSEcCtD
Nimodipine—Phosphatase alkaline increased—Epirubicin—urinary bladder cancer	0.00158	0.00443	CcSEcCtD
Nimodipine—Bradycardia—Cisplatin—urinary bladder cancer	0.00157	0.00441	CcSEcCtD
Nimodipine—Cardiac disorder—Gemcitabine—urinary bladder cancer	0.00154	0.00432	CcSEcCtD
Nimodipine—Jaundice—Etoposide—urinary bladder cancer	0.00154	0.00431	CcSEcCtD
Nimodipine—Angiopathy—Gemcitabine—urinary bladder cancer	0.00151	0.00422	CcSEcCtD
Nimodipine—Fluid retention—Epirubicin—urinary bladder cancer	0.0015	0.00421	CcSEcCtD
Nimodipine—Immune system disorder—Gemcitabine—urinary bladder cancer	0.0015	0.0042	CcSEcCtD
Nimodipine—Hepatobiliary disease—Etoposide—urinary bladder cancer	0.00149	0.00418	CcSEcCtD
Nimodipine—Hypertension—Thiotepa—urinary bladder cancer	0.00148	0.00415	CcSEcCtD
Nimodipine—Phosphatase alkaline increased—Doxorubicin—urinary bladder cancer	0.00146	0.0041	CcSEcCtD
Nimodipine—Myalgia—Thiotepa—urinary bladder cancer	0.00146	0.0041	CcSEcCtD
Nimodipine—Flushing—Cisplatin—urinary bladder cancer	0.00144	0.00402	CcSEcCtD
Nimodipine—Cardiac disorder—Cisplatin—urinary bladder cancer	0.00144	0.00402	CcSEcCtD
Nimodipine—Immune system disorder—Cisplatin—urinary bladder cancer	0.0014	0.00391	CcSEcCtD
Nimodipine—Fluid retention—Doxorubicin—urinary bladder cancer	0.00139	0.00389	CcSEcCtD
Nimodipine—Nervous system disorder—Thiotepa—urinary bladder cancer	0.00137	0.00385	CcSEcCtD
Nimodipine—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00137	0.00385	CcSEcCtD
Nimodipine—Tachycardia—Thiotepa—urinary bladder cancer	0.00137	0.00383	CcSEcCtD
Nimodipine—Anaemia—Gemcitabine—urinary bladder cancer	0.00133	0.00374	CcSEcCtD
Nimodipine—Phlebitis—Epirubicin—urinary bladder cancer	0.00133	0.00373	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Epirubicin—urinary bladder cancer	0.00132	0.0037	CcSEcCtD
Nimodipine—Flushing—Etoposide—urinary bladder cancer	0.00131	0.00369	CcSEcCtD
Nimodipine—Cardiac disorder—Etoposide—urinary bladder cancer	0.00131	0.00369	CcSEcCtD
Nimodipine—Anaemia—Fluorouracil—urinary bladder cancer	0.00131	0.00368	CcSEcCtD
Nimodipine—Muscle spasms—Cisplatin—urinary bladder cancer	0.00129	0.00363	CcSEcCtD
Nimodipine—Angiopathy—Etoposide—urinary bladder cancer	0.00129	0.0036	CcSEcCtD
Nimodipine—Immune system disorder—Etoposide—urinary bladder cancer	0.00128	0.00359	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.00128	0.00358	CcSEcCtD
Nimodipine—Cardiac failure congestive—Epirubicin—urinary bladder cancer	0.00127	0.00355	CcSEcCtD
Nimodipine—Hypertension—Gemcitabine—urinary bladder cancer	0.00125	0.00349	CcSEcCtD
Nimodipine—Anaemia—Cisplatin—urinary bladder cancer	0.00124	0.00349	CcSEcCtD
Nimodipine—Phlebitis—Doxorubicin—urinary bladder cancer	0.00123	0.00346	CcSEcCtD
Nimodipine—Myalgia—Gemcitabine—urinary bladder cancer	0.00123	0.00345	CcSEcCtD
Nimodipine—Blood alkaline phosphatase increased—Doxorubicin—urinary bladder cancer	0.00122	0.00342	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00121	0.00339	CcSEcCtD
Nimodipine—Myalgia—Fluorouracil—urinary bladder cancer	0.00121	0.00339	CcSEcCtD
Nimodipine—Muscle spasms—Etoposide—urinary bladder cancer	0.00119	0.00332	CcSEcCtD
Nimodipine—Oedema—Gemcitabine—urinary bladder cancer	0.00118	0.0033	CcSEcCtD
Nimodipine—Cardiac failure congestive—Doxorubicin—urinary bladder cancer	0.00117	0.00328	CcSEcCtD
Nimodipine—Oedema—Fluorouracil—urinary bladder cancer	0.00116	0.00325	CcSEcCtD
Nimodipine—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.00116	0.00324	CcSEcCtD
Nimodipine—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00115	0.00323	CcSEcCtD
Nimodipine—Hyponatraemia—Epirubicin—urinary bladder cancer	0.00115	0.00323	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Epirubicin—urinary bladder cancer	0.00115	0.00322	CcSEcCtD
Nimodipine—Myalgia—Cisplatin—urinary bladder cancer	0.00115	0.00321	CcSEcCtD
Nimodipine—Anaemia—Etoposide—urinary bladder cancer	0.00114	0.00319	CcSEcCtD
Nimodipine—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00114	0.00319	CcSEcCtD
Nimodipine—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.00114	0.00319	CcSEcCtD
Nimodipine—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.00113	0.00318	CcSEcCtD
Nimodipine—Liver function test abnormal—Methotrexate—urinary bladder cancer	0.00113	0.00317	CcSEcCtD
Nimodipine—Tachycardia—Fluorouracil—urinary bladder cancer	0.00113	0.00317	CcSEcCtD
Nimodipine—Hypotension—Gemcitabine—urinary bladder cancer	0.0011	0.00309	CcSEcCtD
Nimodipine—Oedema—Cisplatin—urinary bladder cancer	0.0011	0.00308	CcSEcCtD
Nimodipine—Hypotension—Fluorouracil—urinary bladder cancer	0.00108	0.00304	CcSEcCtD
Nimodipine—Nervous system disorder—Cisplatin—urinary bladder cancer	0.00108	0.00302	CcSEcCtD
Nimodipine—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00108	0.00302	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00107	0.00301	CcSEcCtD
Nimodipine—Tachycardia—Cisplatin—urinary bladder cancer	0.00107	0.00301	CcSEcCtD
Nimodipine—Hyponatraemia—Doxorubicin—urinary bladder cancer	0.00107	0.00299	CcSEcCtD
Nimodipine—Hypertension—Etoposide—urinary bladder cancer	0.00106	0.00298	CcSEcCtD
Nimodipine—Gastrointestinal haemorrhage—Doxorubicin—urinary bladder cancer	0.00106	0.00298	CcSEcCtD
Nimodipine—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00106	0.00298	CcSEcCtD
Nimodipine—Liver function test abnormal—Epirubicin—urinary bladder cancer	0.00106	0.00297	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00106	0.00296	CcSEcCtD
Nimodipine—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00105	0.00295	CcSEcCtD
Nimodipine—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00103	0.0029	CcSEcCtD
Nimodipine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00103	0.00289	CcSEcCtD
Nimodipine—Hypotension—Cisplatin—urinary bladder cancer	0.00103	0.00288	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00102	0.00285	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Epirubicin—urinary bladder cancer	0.00101	0.00284	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.001	0.00281	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.001	0.0028	CcSEcCtD
Nimodipine—Pruritus—Thiotepa—urinary bladder cancer	0.000991	0.00278	CcSEcCtD
Nimodipine—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000985	0.00276	CcSEcCtD
Nimodipine—Tachycardia—Etoposide—urinary bladder cancer	0.000982	0.00275	CcSEcCtD
Nimodipine—Liver function test abnormal—Doxorubicin—urinary bladder cancer	0.000981	0.00275	CcSEcCtD
Nimodipine—Dyspnoea—Cisplatin—urinary bladder cancer	0.000979	0.00275	CcSEcCtD
Nimodipine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000973	0.00273	CcSEcCtD
Nimodipine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000959	0.00269	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000948	0.00266	CcSEcCtD
Nimodipine—Depression—Methotrexate—urinary bladder cancer	0.000942	0.00264	CcSEcCtD
Nimodipine—Hypotension—Etoposide—urinary bladder cancer	0.00094	0.00264	CcSEcCtD
Nimodipine—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000937	0.00263	CcSEcCtD
Nimodipine—Dizziness—Thiotepa—urinary bladder cancer	0.000927	0.0026	CcSEcCtD
Nimodipine—Dyspnoea—Etoposide—urinary bladder cancer	0.000897	0.00252	CcSEcCtD
Nimodipine—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000894	0.00251	CcSEcCtD
Nimodipine—Vomiting—Thiotepa—urinary bladder cancer	0.000891	0.0025	CcSEcCtD
Nimodipine—Rash—Thiotepa—urinary bladder cancer	0.000883	0.00248	CcSEcCtD
Nimodipine—Dermatitis—Thiotepa—urinary bladder cancer	0.000883	0.00247	CcSEcCtD
Nimodipine—Headache—Thiotepa—urinary bladder cancer	0.000878	0.00246	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000869	0.00244	CcSEcCtD
Nimodipine—Jaundice—Epirubicin—urinary bladder cancer	0.000862	0.00242	CcSEcCtD
Nimodipine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000854	0.00239	CcSEcCtD
Nimodipine—Hepatitis—Methotrexate—urinary bladder cancer	0.000849	0.00238	CcSEcCtD
Nimodipine—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000837	0.00234	CcSEcCtD
Nimodipine—Pruritus—Gemcitabine—urinary bladder cancer	0.000834	0.00234	CcSEcCtD
Nimodipine—Nausea—Thiotepa—urinary bladder cancer	0.000832	0.00233	CcSEcCtD
Nimodipine—Pruritus—Fluorouracil—urinary bladder cancer	0.00082	0.0023	CcSEcCtD
Nimodipine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000809	0.00227	CcSEcCtD
Nimodipine—Bradycardia—Epirubicin—urinary bladder cancer	0.000808	0.00227	CcSEcCtD
Nimodipine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000806	0.00226	CcSEcCtD
Nimodipine—Jaundice—Doxorubicin—urinary bladder cancer	0.000798	0.00224	CcSEcCtD
Nimodipine—Hepatitis—Epirubicin—urinary bladder cancer	0.000794	0.00223	CcSEcCtD
Nimodipine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000793	0.00222	CcSEcCtD
Nimodipine—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000787	0.00221	CcSEcCtD
Nimodipine—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000774	0.00217	CcSEcCtD
Nimodipine—Angiopathy—Methotrexate—urinary bladder cancer	0.00077	0.00216	CcSEcCtD
Nimodipine—Immune system disorder—Methotrexate—urinary bladder cancer	0.000766	0.00215	CcSEcCtD
Nimodipine—Dizziness—Fluorouracil—urinary bladder cancer	0.000766	0.00215	CcSEcCtD
Nimodipine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000752	0.00211	CcSEcCtD
Nimodipine—Vomiting—Gemcitabine—urinary bladder cancer	0.000749	0.0021	CcSEcCtD
Nimodipine—Bradycardia—Doxorubicin—urinary bladder cancer	0.000748	0.0021	CcSEcCtD
Nimodipine—Rash—Gemcitabine—urinary bladder cancer	0.000743	0.00208	CcSEcCtD
Nimodipine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000742	0.00208	CcSEcCtD
Nimodipine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000742	0.00208	CcSEcCtD
Nimodipine—Headache—Gemcitabine—urinary bladder cancer	0.000738	0.00207	CcSEcCtD
Nimodipine—Flushing—Epirubicin—urinary bladder cancer	0.000737	0.00207	CcSEcCtD
Nimodipine—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000737	0.00207	CcSEcCtD
Nimodipine—Vomiting—Fluorouracil—urinary bladder cancer	0.000737	0.00207	CcSEcCtD
Nimodipine—Hepatitis—Doxorubicin—urinary bladder cancer	0.000735	0.00206	CcSEcCtD
Nimodipine—Rash—Fluorouracil—urinary bladder cancer	0.000731	0.00205	CcSEcCtD
Nimodipine—Dermatitis—Fluorouracil—urinary bladder cancer	0.00073	0.00205	CcSEcCtD
Nimodipine—Headache—Fluorouracil—urinary bladder cancer	0.000726	0.00203	CcSEcCtD
Nimodipine—Angiopathy—Epirubicin—urinary bladder cancer	0.00072	0.00202	CcSEcCtD
Nimodipine—Immune system disorder—Epirubicin—urinary bladder cancer	0.000717	0.00201	CcSEcCtD
Nimodipine—Pruritus—Etoposide—urinary bladder cancer	0.000712	0.002	CcSEcCtD
Nimodipine—Nausea—Gemcitabine—urinary bladder cancer	0.0007	0.00196	CcSEcCtD
Nimodipine—Vomiting—Cisplatin—urinary bladder cancer	0.000698	0.00196	CcSEcCtD
Nimodipine—Rash—Cisplatin—urinary bladder cancer	0.000693	0.00194	CcSEcCtD
Nimodipine—Dermatitis—Cisplatin—urinary bladder cancer	0.000692	0.00194	CcSEcCtD
Nimodipine—Diarrhoea—Etoposide—urinary bladder cancer	0.000689	0.00193	CcSEcCtD
Nimodipine—Nausea—Fluorouracil—urinary bladder cancer	0.000688	0.00193	CcSEcCtD
Nimodipine—Anaemia—Methotrexate—urinary bladder cancer	0.000683	0.00191	CcSEcCtD
Nimodipine—Flushing—Doxorubicin—urinary bladder cancer	0.000682	0.00191	CcSEcCtD
Nimodipine—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000682	0.00191	CcSEcCtD
Nimodipine—Angiopathy—Doxorubicin—urinary bladder cancer	0.000667	0.00187	CcSEcCtD
Nimodipine—Dizziness—Etoposide—urinary bladder cancer	0.000666	0.00187	CcSEcCtD
Nimodipine—Muscle spasms—Epirubicin—urinary bladder cancer	0.000665	0.00186	CcSEcCtD
Nimodipine—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000664	0.00186	CcSEcCtD
Nimodipine—Nausea—Cisplatin—urinary bladder cancer	0.000653	0.00183	CcSEcCtD
Nimodipine—Vomiting—Etoposide—urinary bladder cancer	0.00064	0.00179	CcSEcCtD
Nimodipine—Anaemia—Epirubicin—urinary bladder cancer	0.000639	0.00179	CcSEcCtD
Nimodipine—Rash—Etoposide—urinary bladder cancer	0.000635	0.00178	CcSEcCtD
Nimodipine—Dermatitis—Etoposide—urinary bladder cancer	0.000634	0.00178	CcSEcCtD
Nimodipine—Headache—Etoposide—urinary bladder cancer	0.00063	0.00177	CcSEcCtD
Nimodipine—Myalgia—Methotrexate—urinary bladder cancer	0.000629	0.00176	CcSEcCtD
Nimodipine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000615	0.00172	CcSEcCtD
Nimodipine—Palpitations—Epirubicin—urinary bladder cancer	0.000611	0.00171	CcSEcCtD
Nimodipine—Nausea—Etoposide—urinary bladder cancer	0.000598	0.00168	CcSEcCtD
Nimodipine—Hypertension—Epirubicin—urinary bladder cancer	0.000597	0.00167	CcSEcCtD
Nimodipine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000591	0.00166	CcSEcCtD
Nimodipine—Anaemia—Doxorubicin—urinary bladder cancer	0.000591	0.00166	CcSEcCtD
Nimodipine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00059	0.00165	CcSEcCtD
Nimodipine—Myalgia—Epirubicin—urinary bladder cancer	0.000589	0.00165	CcSEcCtD
Nimodipine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000583	0.00163	CcSEcCtD
Nimodipine—Palpitations—Doxorubicin—urinary bladder cancer	0.000565	0.00158	CcSEcCtD
Nimodipine—Oedema—Epirubicin—urinary bladder cancer	0.000564	0.00158	CcSEcCtD
Nimodipine—Hypotension—Methotrexate—urinary bladder cancer	0.000563	0.00158	CcSEcCtD
Nimodipine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000553	0.00155	CcSEcCtD
Nimodipine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000552	0.00155	CcSEcCtD
Nimodipine—Hypertension—Doxorubicin—urinary bladder cancer	0.000552	0.00155	CcSEcCtD
Nimodipine—Tachycardia—Epirubicin—urinary bladder cancer	0.000551	0.00154	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000549	0.00154	CcSEcCtD
Nimodipine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000545	0.00153	CcSEcCtD
Nimodipine—Myalgia—Doxorubicin—urinary bladder cancer	0.000545	0.00153	CcSEcCtD
Nimodipine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000537	0.00151	CcSEcCtD
Nimodipine—Hypotension—Epirubicin—urinary bladder cancer	0.000527	0.00148	CcSEcCtD
Nimodipine—Oedema—Doxorubicin—urinary bladder cancer	0.000522	0.00146	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00052	0.00146	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000514	0.00144	CcSEcCtD
Nimodipine—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000512	0.00143	CcSEcCtD
Nimodipine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000511	0.00143	CcSEcCtD
Nimodipine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000509	0.00143	CcSEcCtD
Nimodipine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000505	0.00141	CcSEcCtD
Nimodipine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000503	0.00141	CcSEcCtD
Nimodipine—Hypotension—Doxorubicin—urinary bladder cancer	0.000488	0.00137	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000487	0.00137	CcSEcCtD
Nimodipine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000476	0.00133	CcSEcCtD
Nimodipine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000465	0.0013	CcSEcCtD
Nimodipine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000451	0.00126	CcSEcCtD
Nimodipine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000444	0.00124	CcSEcCtD
Nimodipine—Pruritus—Methotrexate—urinary bladder cancer	0.000427	0.0012	CcSEcCtD
Nimodipine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000416	0.00117	CcSEcCtD
Nimodipine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000412	0.00116	CcSEcCtD
Nimodipine—Pruritus—Epirubicin—urinary bladder cancer	0.000399	0.00112	CcSEcCtD
Nimodipine—Dizziness—Methotrexate—urinary bladder cancer	0.000399	0.00112	CcSEcCtD
Nimodipine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000386	0.00108	CcSEcCtD
Nimodipine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000385	0.00108	CcSEcCtD
Nimodipine—Vomiting—Methotrexate—urinary bladder cancer	0.000383	0.00107	CcSEcCtD
Nimodipine—Rash—Methotrexate—urinary bladder cancer	0.00038	0.00107	CcSEcCtD
Nimodipine—Dermatitis—Methotrexate—urinary bladder cancer	0.00038	0.00106	CcSEcCtD
Nimodipine—Headache—Methotrexate—urinary bladder cancer	0.000378	0.00106	CcSEcCtD
Nimodipine—Dizziness—Epirubicin—urinary bladder cancer	0.000373	0.00105	CcSEcCtD
Nimodipine—Pruritus—Doxorubicin—urinary bladder cancer	0.000369	0.00104	CcSEcCtD
Nimodipine—Vomiting—Epirubicin—urinary bladder cancer	0.000359	0.00101	CcSEcCtD
Nimodipine—Nausea—Methotrexate—urinary bladder cancer	0.000358	0.001	CcSEcCtD
Nimodipine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000357	0.001	CcSEcCtD
Nimodipine—Rash—Epirubicin—urinary bladder cancer	0.000356	0.000997	CcSEcCtD
Nimodipine—Dermatitis—Epirubicin—urinary bladder cancer	0.000355	0.000996	CcSEcCtD
Nimodipine—Headache—Epirubicin—urinary bladder cancer	0.000353	0.000991	CcSEcCtD
Nimodipine—Dizziness—Doxorubicin—urinary bladder cancer	0.000345	0.000968	CcSEcCtD
Nimodipine—Nausea—Epirubicin—urinary bladder cancer	0.000335	0.000939	CcSEcCtD
Nimodipine—Vomiting—Doxorubicin—urinary bladder cancer	0.000332	0.00093	CcSEcCtD
Nimodipine—Rash—Doxorubicin—urinary bladder cancer	0.000329	0.000923	CcSEcCtD
Nimodipine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000329	0.000922	CcSEcCtD
Nimodipine—Headache—Doxorubicin—urinary bladder cancer	0.000327	0.000917	CcSEcCtD
Nimodipine—Nausea—Doxorubicin—urinary bladder cancer	0.00031	0.000869	CcSEcCtD
Nimodipine—CACNB3—Developmental Biology—ERBB2—urinary bladder cancer	0.000268	0.000764	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—ERBB2—urinary bladder cancer	0.000268	0.000763	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—SRC—urinary bladder cancer	0.000265	0.000756	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—GSTP1—urinary bladder cancer	0.000265	0.000755	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PRSS3—urinary bladder cancer	0.000263	0.00075	CbGpPWpGaD
Nimodipine—CACNB4—Axon guidance—HRAS—urinary bladder cancer	0.000262	0.000745	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—CDK4—urinary bladder cancer	0.000261	0.000745	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000261	0.000744	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—ERBB2—urinary bladder cancer	0.000261	0.000743	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—EGFR—urinary bladder cancer	0.00026	0.000742	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—EGFR—urinary bladder cancer	0.000253	0.000722	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—TYMP—urinary bladder cancer	0.000253	0.000721	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—RHOA—urinary bladder cancer	0.000248	0.000707	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—KRAS—urinary bladder cancer	0.000246	0.000701	CbGpPWpGaD
Nimodipine—CYP3A5—Biological oxidations—GSTM1—urinary bladder cancer	0.000243	0.000693	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—NQO1—urinary bladder cancer	0.000241	0.000688	CbGpPWpGaD
Nimodipine—CYP3A5—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.00024	0.000684	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—TYMP—urinary bladder cancer	0.00024	0.000683	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—KRAS—urinary bladder cancer	0.000239	0.000682	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—PPARG—urinary bladder cancer	0.000237	0.000677	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—NCOR1—urinary bladder cancer	0.000236	0.000674	CbGpPWpGaD
Nimodipine—CACNB3—Neuronal System—HRAS—urinary bladder cancer	0.000236	0.000672	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—RHOA—urinary bladder cancer	0.000235	0.000669	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—EGFR—urinary bladder cancer	0.000232	0.000662	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—MMP9—urinary bladder cancer	0.00023	0.000655	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—MMP9—urinary bladder cancer	0.00023	0.000654	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—ERBB2—urinary bladder cancer	0.00023	0.000654	CbGpPWpGaD
Nimodipine—CACNB1—Neuronal System—HRAS—urinary bladder cancer	0.000229	0.000653	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000229	0.000653	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—NAT2—urinary bladder cancer	0.000229	0.000652	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—CREBBP—urinary bladder cancer	0.000228	0.00065	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000226	0.000644	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—CDK4—urinary bladder cancer	0.000224	0.000639	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—MMP9—urinary bladder cancer	0.000224	0.000637	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—TNF—urinary bladder cancer	0.000221	0.000631	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—KRAS—urinary bladder cancer	0.00022	0.000626	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—EP300—urinary bladder cancer	0.000218	0.000621	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—ERBB2—urinary bladder cancer	0.000217	0.000619	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—NAT2—urinary bladder cancer	0.000217	0.000617	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—NCOR1—urinary bladder cancer	0.000214	0.000609	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—CDK4—urinary bladder cancer	0.000212	0.000605	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—EP300—urinary bladder cancer	0.000212	0.000604	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—SRC—urinary bladder cancer	0.000212	0.000604	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—SRC—urinary bladder cancer	0.000212	0.000603	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—TYMP—urinary bladder cancer	0.000211	0.0006	CbGpPWpGaD
Nimodipine—CACNB3—Axon guidance—HRAS—urinary bladder cancer	0.000209	0.000596	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—RHOA—urinary bladder cancer	0.000206	0.000588	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—RHOA—urinary bladder cancer	0.000206	0.000588	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—SRC—urinary bladder cancer	0.000206	0.000588	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—PPARG—urinary bladder cancer	0.000204	0.00058	CbGpPWpGaD
Nimodipine—CACNB1—Axon guidance—HRAS—urinary bladder cancer	0.000203	0.00058	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—GSTP1—urinary bladder cancer	0.000201	0.000574	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—ERCC2—urinary bladder cancer	0.000201	0.000572	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—RRM2—urinary bladder cancer	0.000198	0.000563	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—MMP9—urinary bladder cancer	0.000197	0.000561	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—CREBBP—urinary bladder cancer	0.000196	0.000557	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—PPARG—urinary bladder cancer	0.000193	0.000549	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—ERBB2—urinary bladder cancer	0.000191	0.000544	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—ERBB2—urinary bladder cancer	0.000191	0.000544	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—NAT2—urinary bladder cancer	0.00019	0.000542	CbGpPWpGaD
Nimodipine—CACNB2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	0.000188	0.000535	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—TYMS—urinary bladder cancer	0.000187	0.000533	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—RRM2—urinary bladder cancer	0.000187	0.000533	CbGpPWpGaD
Nimodipine—CACNB4—Developmental Biology—HRAS—urinary bladder cancer	0.000187	0.000532	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—CDK4—urinary bladder cancer	0.000186	0.000531	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—MMP9—urinary bladder cancer	0.000186	0.000531	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—EGFR—urinary bladder cancer	0.000186	0.00053	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—EGFR—urinary bladder cancer	0.000186	0.000529	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—CREBBP—urinary bladder cancer	0.000185	0.000528	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—GSTM1—urinary bladder cancer	0.000185	0.000527	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—NCOR1—urinary bladder cancer	0.000185	0.000527	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000183	0.000522	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—HPGDS—urinary bladder cancer	0.000183	0.000521	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ENO2—urinary bladder cancer	0.000183	0.000521	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—SRC—urinary bladder cancer	0.000182	0.000517	CbGpPWpGaD
Nimodipine—NR3C2—Generic Transcription Pathway—MYC—urinary bladder cancer	0.000181	0.000516	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—EGFR—urinary bladder cancer	0.000181	0.000515	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000178	0.000506	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GSTT1—urinary bladder cancer	0.000177	0.000505	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—GPX1—urinary bladder cancer	0.000177	0.000505	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—TNF—urinary bladder cancer	0.000177	0.000504	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—RHOA—urinary bladder cancer	0.000177	0.000504	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—KRAS—urinary bladder cancer	0.000176	0.0005	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—KRAS—urinary bladder cancer	0.000175	0.0005	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—ERCC2—urinary bladder cancer	0.000174	0.000496	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ENO2—urinary bladder cancer	0.000173	0.000494	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—HPGDS—urinary bladder cancer	0.000173	0.000494	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—TNF—urinary bladder cancer	0.000172	0.000491	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—SRC—urinary bladder cancer	0.000172	0.00049	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—KRAS—urinary bladder cancer	0.000171	0.000487	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—PPARG—urinary bladder cancer	0.000169	0.000483	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GSTT1—urinary bladder cancer	0.000168	0.000479	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—ESR1—urinary bladder cancer	0.000168	0.000478	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—RHOA—urinary bladder cancer	0.000168	0.000477	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—RRM2—urinary bladder cancer	0.000164	0.000468	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—MMP9—urinary bladder cancer	0.000164	0.000467	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—MMP9—urinary bladder cancer	0.000164	0.000467	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—ERBB2—urinary bladder cancer	0.000164	0.000467	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—MTHFR—urinary bladder cancer	0.000163	0.000466	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—CREBBP—urinary bladder cancer	0.000163	0.000464	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTZ1—urinary bladder cancer	0.000162	0.000462	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—EGFR—urinary bladder cancer	0.000159	0.000453	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—EP300—urinary bladder cancer	0.000155	0.000443	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—ERBB2—urinary bladder cancer	0.000155	0.000442	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTO2—urinary bladder cancer	0.000154	0.000438	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NAT1—urinary bladder cancer	0.000154	0.000438	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—PPARG—urinary bladder cancer	0.000153	0.000436	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ENO2—urinary bladder cancer	0.000152	0.000434	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—HPGDS—urinary bladder cancer	0.000152	0.000434	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—SRC—urinary bladder cancer	0.000151	0.000431	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—SRC—urinary bladder cancer	0.000151	0.00043	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—EGFR—urinary bladder cancer	0.000151	0.000429	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—KRAS—urinary bladder cancer	0.00015	0.000428	CbGpPWpGaD
Nimodipine—CACNB3—Developmental Biology—HRAS—urinary bladder cancer	0.000149	0.000425	CbGpPWpGaD
Nimodipine—CACNA1S—Axon guidance—HRAS—urinary bladder cancer	0.000149	0.000425	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTT1—urinary bladder cancer	0.000148	0.000421	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—NQO1—urinary bladder cancer	0.000147	0.00042	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—RHOA—urinary bladder cancer	0.000147	0.00042	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—CREBBP—urinary bladder cancer	0.000147	0.000419	CbGpPWpGaD
Nimodipine—CACNB1—Developmental Biology—HRAS—urinary bladder cancer	0.000145	0.000414	CbGpPWpGaD
Nimodipine—CACNB2—Neuronal System—HRAS—urinary bladder cancer	0.000144	0.00041	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—KRAS—urinary bladder cancer	0.000142	0.000406	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	0.000141	0.000401	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—MMP9—urinary bladder cancer	0.000141	0.0004	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—NQO1—urinary bladder cancer	0.00014	0.000398	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—ERBB2—urinary bladder cancer	0.000136	0.000388	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—EP300—urinary bladder cancer	0.000133	0.00038	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—MMP9—urinary bladder cancer	0.000133	0.000379	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PPARG—urinary bladder cancer	0.000133	0.000378	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—EGFR—urinary bladder cancer	0.000132	0.000377	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—EGFR—urinary bladder cancer	0.000132	0.000377	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—SRC—urinary bladder cancer	0.00013	0.000369	CbGpPWpGaD
Nimodipine—CACNB2—Axon guidance—HRAS—urinary bladder cancer	0.000128	0.000364	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—CREBBP—urinary bladder cancer	0.000127	0.000363	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	0.000127	0.000361	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—EP300—urinary bladder cancer	0.000126	0.000359	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—TNF—urinary bladder cancer	0.000126	0.000359	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—KRAS—urinary bladder cancer	0.000125	0.000356	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—KRAS—urinary bladder cancer	0.000125	0.000356	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	0.000123	0.000351	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GSTP1—urinary bladder cancer	0.000123	0.00035	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—NQO1—urinary bladder cancer	0.000123	0.00035	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—SRC—urinary bladder cancer	0.000123	0.00035	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000121	0.000346	CbGpPWpGaD
Nimodipine—CACNA1D—Axon guidance—HRAS—urinary bladder cancer	0.000121	0.000345	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	0.00012	0.000341	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—MMP9—urinary bladder cancer	0.000117	0.000333	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	0.000117	0.000332	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GSTP1—urinary bladder cancer	0.000116	0.000332	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—TYMS—urinary bladder cancer	0.000114	0.000326	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—EGFR—urinary bladder cancer	0.000114	0.000324	CbGpPWpGaD
Nimodipine—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	0.000113	0.000322	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—NCOR1—urinary bladder cancer	0.000113	0.000322	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GSTM1—urinary bladder cancer	0.000113	0.000322	CbGpPWpGaD
Nimodipine—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000112	0.000318	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—EP300—urinary bladder cancer	0.000111	0.000316	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—TYMS—urinary bladder cancer	0.000108	0.000308	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—GPX1—urinary bladder cancer	0.000108	0.000308	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—TNF—urinary bladder cancer	0.000108	0.000308	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—SRC—urinary bladder cancer	0.000108	0.000307	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—EGFR—urinary bladder cancer	0.000108	0.000306	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—KRAS—urinary bladder cancer	0.000107	0.000306	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—NCOR1—urinary bladder cancer	0.000107	0.000305	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GSTM1—urinary bladder cancer	0.000107	0.000305	CbGpPWpGaD
Nimodipine—CACNA1S—Developmental Biology—HRAS—urinary bladder cancer	0.000106	0.000303	CbGpPWpGaD
Nimodipine—CACNA1C—Axon guidance—HRAS—urinary bladder cancer	0.000106	0.000303	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—ERCC2—urinary bladder cancer	0.000106	0.000303	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PTGS2—urinary bladder cancer	0.000104	0.000297	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—GPX1—urinary bladder cancer	0.000102	0.000292	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—TNF—urinary bladder cancer	0.000102	0.000292	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTP1—urinary bladder cancer	0.000102	0.000292	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—KRAS—urinary bladder cancer	0.000102	0.000289	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—ERCC2—urinary bladder cancer	0.000101	0.000287	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—MTHFR—urinary bladder cancer	9.99e-05	0.000285	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—TYMS—urinary bladder cancer	9.51e-05	0.000271	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—MTHFR—urinary bladder cancer	9.46e-05	0.000269	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—EGFR—urinary bladder cancer	9.45e-05	0.000269	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—NCOR1—urinary bladder cancer	9.4e-05	0.000268	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GSTM1—urinary bladder cancer	9.4e-05	0.000268	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—TYMP—urinary bladder cancer	9.32e-05	0.000265	CbGpPWpGaD
Nimodipine—CACNB2—Developmental Biology—HRAS—urinary bladder cancer	9.12e-05	0.00026	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—PTEN—urinary bladder cancer	9.09e-05	0.000259	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—GPX1—urinary bladder cancer	9e-05	0.000257	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—TNF—urinary bladder cancer	9e-05	0.000256	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—KRAS—urinary bladder cancer	8.93e-05	0.000254	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—ERCC2—urinary bladder cancer	8.84e-05	0.000252	CbGpPWpGaD
Nimodipine—NR3C2—Gene Expression—MYC—urinary bladder cancer	8.73e-05	0.000249	CbGpPWpGaD
Nimodipine—CACNB3—Metabolism—EP300—urinary bladder cancer	8.67e-05	0.000247	CbGpPWpGaD
Nimodipine—CACNA1D—Developmental Biology—HRAS—urinary bladder cancer	8.63e-05	0.000246	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NAT2—urinary bladder cancer	8.43e-05	0.00024	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—MTHFR—urinary bladder cancer	8.31e-05	0.000237	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PPARG—urinary bladder cancer	8.1e-05	0.000231	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—CREBBP—urinary bladder cancer	7.78e-05	0.000222	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PPARG—urinary bladder cancer	7.67e-05	0.000219	CbGpPWpGaD
Nimodipine—CACNA1C—Developmental Biology—HRAS—urinary bladder cancer	7.59e-05	0.000216	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	7.54e-05	0.000215	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—CREBBP—urinary bladder cancer	7.37e-05	0.00021	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—RRM2—urinary bladder cancer	7.27e-05	0.000207	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	7.15e-05	0.000204	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	7.15e-05	0.000204	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PPARG—urinary bladder cancer	6.74e-05	0.000192	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ENO2—urinary bladder cancer	6.74e-05	0.000192	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	6.74e-05	0.000192	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	6.54e-05	0.000186	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	6.53e-05	0.000186	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—CREBBP—urinary bladder cancer	6.47e-05	0.000184	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PTGS2—urinary bladder cancer	6.37e-05	0.000182	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PTGS2—urinary bladder cancer	6.03e-05	0.000172	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	5.89e-05	0.000168	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	5.56e-05	0.000158	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—PTEN—urinary bladder cancer	5.56e-05	0.000158	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NQO1—urinary bladder cancer	5.43e-05	0.000155	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	5.42e-05	0.000154	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PTGS2—urinary bladder cancer	5.3e-05	0.000151	CbGpPWpGaD
Nimodipine—CACNB2—Metabolism—EP300—urinary bladder cancer	5.3e-05	0.000151	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—PTEN—urinary bladder cancer	5.26e-05	0.00015	CbGpPWpGaD
Nimodipine—CACNA1D—Metabolism—EP300—urinary bladder cancer	5.02e-05	0.000143	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—PTEN—urinary bladder cancer	4.62e-05	0.000132	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	4.53e-05	0.000129	CbGpPWpGaD
Nimodipine—CACNA1C—Metabolism—EP300—urinary bladder cancer	4.41e-05	0.000126	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	4.33e-05	0.000123	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—TYMS—urinary bladder cancer	4.21e-05	0.00012	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	4.16e-05	0.000119	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	4.16e-05	0.000119	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—GPX1—urinary bladder cancer	3.99e-05	0.000114	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	3.92e-05	0.000112	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	3.91e-05	0.000111	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	3.68e-05	0.000105	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	3.38e-05	9.64e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	3.13e-05	8.92e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	3.13e-05	8.92e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	3.04e-05	8.66e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PPARG—urinary bladder cancer	2.98e-05	8.5e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	2.87e-05	8.16e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.52e-05	7.19e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	2.35e-05	6.69e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	2.11e-05	6e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—PTEN—urinary bladder cancer	2.05e-05	5.83e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.96e-05	5.58e-05	CbGpPWpGaD
Nimodipine—CYP3A5—Metabolism—EP300—urinary bladder cancer	1.95e-05	5.56e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.94e-05	5.51e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.94e-05	5.51e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.85e-05	5.28e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.82e-05	5.18e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.71e-05	4.87e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.39e-05	3.95e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.33e-05	3.8e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.09e-05	3.11e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	9.51e-06	2.71e-05	CbGpPWpGaD
Nimodipine—CYP3A4—Metabolism—EP300—urinary bladder cancer	9.07e-06	2.58e-05	CbGpPWpGaD
